We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
-17.82%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.57B
AUM Growth
-$3.55B
Cap. Flow
-$2.73B
Cap. Flow %
-106.24%
Top 10 Hldgs %
17.09%
Holding
725
New
147
Increased
124
Reduced
128
Closed
321

Top Buys

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$63.3M
2
EVRG icon
Evergy
EVRG
+$48.2M
3
AVYA
Avaya Holdings Corp. Common Stock
AVYA
+$47M
4
WELL icon
Welltower
WELL
+$39.8M
5
AMZN icon
Amazon
AMZN
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 25.53%
2 Industrials 15.74%
3 Real Estate 14.46%
4 Healthcare 11%
5 Utilities 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVS
376
DELISTED
Clovis Oncology, Inc.
CLVS
$278K 0.01%
43,633
-24,367
-36% -$195K
PFE icon
377
Pfizer
PFE
$142B
$268K 0.01%
+8,669
New +$295K
DCPH
378
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$264K 0.01%
+6,410
New +$356K
SAVE
379
DELISTED
Spirit Airlines, Inc.
SAVE
$258K 0.01%
20,000
-119,870
-86% -$3.85M
KO icon
380
Coca-Cola
KO
$381B
$251K 0.01%
5,673
-171,019
-97% -$9.24M
MDB icon
381
MongoDB
MDB
$26.2B
$246K 0.01%
+1,801
New +$266K
PTON icon
382
Peloton Interactive
PTON
$2.76B
$241K 0.01%
+9,075
New +$252K
TVRD
383
Tvardi Therapeutics
TVRD
$19.7M
$234K 0.01%
493
+215
+77% +$117K
VIXY icon
384
ProShares VIX Short-Term Futures ETF
VIXY
$206M
$215K 0.01%
71
-304
-81% -$509K
FATE icon
385
Fate Therapeutics
FATE
$293M
$214K 0.01%
9,630
-370
-4% -$9.36K
MNTA
386
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$212K 0.01%
+7,808
New +$217K
QURE icon
387
uniQure
QURE
$2.93B
$206K 0.01%
+4,332
New +$249K
KPTI icon
388
Karyopharm Therapeutics
KPTI
$159M
$204K 0.01%
707
-293
-29% -$80.8K
AZN icon
389
CALL
AstraZeneca
AZN
$266B
$201K 0.01%
+2,250
New +$212K
ICAD
390
DELISTED
iCAD Inc
ICAD
$185K 0.01%
+25,164
New +$245K
ACH
391
Accendra Health
ACH
$256M
$185K 0.01%
20,224
-776
-4% -$4.68K
GNMK
392
DELISTED
GenMark Diagnostics, Inc
GNMK
$172K 0.01%
41,761
-48,239
-54% -$226K
TXMD icon
393
TherapeuticsMD
TXMD
$23.5M
$158K 0.01%
2,980
-110
-4% -$10.9K
FENC icon
394
Fennec Pharmaceuticals
FENC
$344M
$151K 0.01%
25,439
-1,061
-4% -$6.92K
VYGR icon
395
Voyager Therapeutics
VYGR
$189M
$150K 0.01%
16,353
+353
+2% +$4.05K
KALV
396
DELISTED
KalVista Pharmaceuticals
KALV
$147K 0.01%
19,261
-739
-4% -$9.97K
TDAY
397
USA Today Co
TDAY
$1.28B
$132K 0.01%
+88,940
New +$439K
DVAX
398
DELISTED
Dynavax Technologies
DVAX
$130K 0.01%
36,688
-11,312
-24% -$52.4K
SGMO
399
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$117K ﹤0.01%
18,344
-11,656
-39% -$86.5K
BRQS
400
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$102K ﹤0.01%
486

Similar funds

Weiss Multi-Strategy Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, Weiss Multi-Strategy Advisers held 725 positions worth $2.57B, down 58% from $6.12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $2.73B in Q1 2020, closing 321 positions and reducing 128 holdings. Its most notable exit was Zayo Group Holdings, Inc., an estimated $87.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 14% a quarter earlier, followed by Industrials and Real Estate.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Evergy worth $40.3M.

  • Weiss Multi-Strategy Advisers's largest Q1 2020 buy was Evergy: 732,959 shares worth $40.3M.
  • Weiss Multi-Strategy Advisers added most to Vertiv in Q1 2020, an estimated $63.3M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2020 reduction was Citigroup, cutting an estimated $58.4M.
  • Weiss Multi-Strategy Advisers fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $87.2M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 17% of its $2.57B portfolio in Q1 2020.
  • Weiss Multi-Strategy Advisers opened 147 new positions and closed 321 in Q1 2020.
  • Weiss Multi-Strategy Advisers's portfolio value fell 58% quarter-over-quarter to $2.57B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.